Immuneering (IMRX) Stock Price, Quote, News & History | Benzinga

Immuneering Corp (IMRX) Stock Price, Quote, News & History

IMRXNASDAQ

Trade with Public

Trade with Public

$4.48

-0.07-1.54%

At close: Jun 4, 5:00 PM EST

$4.47

-0.0109-0.24%

After Hours: 4:26 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$4.49

Close

$4.48

Volume / Avg.

1.06M / 1.30M

Day Range

$4.47 - $4.67

52 Wk Range

1.66 - 10.08

Market Cap

$289.14M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

20.15%

Days to Cover

14.91

Recent Immuneering Corp News

Immuneering Pancreatic Cancer Trial Touts Encouraging Survival Data, But Stock Moves Lower

Immuneering shares traded lower after new pancreatic cancer trial data showed improved survival, manageable safety, and key trial milestones expected in 2026.

Vandana Singh

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Drop— AZZ, Northrop Grumman, Immuneering In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures declined on Thursday following a mixed close on Tuesday, with only the Nasdaq 100 index ending in green.

Rishabh Mishra

Why Is Immuneering Stock Trading Higher On Tuesday?

Immuneering reveals promising Phase 2a pancreatic cancer trial updates for IMM-1-104, showcasing efficacy, safety, and future expansion plans.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-49.70M

Investing Cash Flow (TTM)

-151.80M

Financing Cash Flow (TTM)

212.95M

Free Cash Flow (TTM)

-49.91M

Capital Expenditure (TTM)

-213.21K

Net Change in Cash (TTM)

11.46M

Analyst Trends and Forecast

1

Mar

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$137.85M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.43

Earnings Yield % (TTM)

-23.30%

Earnings Yield % (FWD)

-20.88%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.19

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$47.32M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$4.49

Close

$4.48

Volume / Avg.

1.06M / 1.30M

Day Range

$4.47 - $4.67

52 Wk Range

1.66 - 10.08

Market Cap

$289.14M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

20.15%

Days to Cover

14.91

About

Sector

Health Care

Industry

Biotechnology

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immuneering (IMRX) competitors?

A

There are no as such competitors for Immuneering.

Q

What is the forecast, or price target, for Immuneering (IMRX) stock?

A

Immuneering has a consensus price target of $15.44.

Q

What is the current price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $4.4691 last updated June 4, 2026 at 4:26 PM EDT.

Q

Does Immuneering (IMRX) pay a dividend?

A

There are no upcoming dividends for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A

Immuneering does not have any upcoming earnings scheduled.

Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.